ArticleCureus2025
Primary Mediastinal Germ Cell Tumor in a Woman Presenting With Superior Vena Cava Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mediastinal germ cell tumors (MGCTs) are rare neoplasms that typically occur in young men, with nonseminomatous subtypes predominating in this population. The occurrence of such tumors in women is exceedingly uncommon, accounting for a very small fraction of all extragonadal germ cell tumors (GCTs). We present a rare case of a 44-year-old woman diagnosed with a primary mediastinal germ cell tumor (PMGCT) complicated by superior vena cava (SVC) syndrome. The patient initially presented with severe respiratory distress, chest pain, and signs of venous congestion. Imaging revealed a large anterior mediastinal mass compressing the SVC. She was started on systemic chemotherapy with cisplatin and bleomycin, with partial symptomatic relief. Her hospital course was further complicated by anemia, volume overload, and pulmonary infiltrates. This case underscores the importance of considering MGCTs in the differential diagnosis of anterior mediastinal masses in women and highlights the potential for life-threatening complications such as SVC syndrome. Prompt recognition and multidisciplinary management are essential to improving outcomes in these rare but aggressive tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.